SimonAE, AkinbamiLJ. Asthma action plan receipt among children with asthma 2–17 years of age, United States, 2001–2013. J Pediatr, 2016. [Epub ahead of print]; DOI: 10.1016/j.jpeds.2016.01.004.
2.
AkinbamiLJ, SimonAE, RossenLM. Changing trends in asthma prevalence among children. Pediatrics, 2016; 137:1–7.
3.
KelsoJM. Do written asthma action plans improve outcomes?. Pediatr Allergy Immunol Pulmonol, 2016; 29:2–5.
4.
SafiKH, Stoermer-GrossmanK, KidwellKM, SturzaJM, RamirezIA, SabaTG, HersensonMB, LewisTC, ArtetaM. A comprehensive pediatric asthma management program reduces emergency department visits and hospitalizations. Pediatr Allergy Immunol Pulmonol, 2016; 29:17–23.
5.
LevineGK, DattaS, BabbittCJ. Infections and asthma in the pediatric intensive care unit: Prevalence and contribution to disease severity. Pediatr Allergy Immunol Pulmonol, 2016; 29:44–48.
6.
BlakeK, RaissyH. Mepolizumab: A new class of treatment for adolescents with severe persistent asthma. Pediatr Allergy Immunol Pulmonol, 2016; 29:49–52.
